NEW YORK (360Dx) – Medite Cancer Diagnostics today announced the closing of $5.4 million in private financing with GPB Debt Holdings to fund a growth strategy focused on bringing new cancer diagnostics to market. The financing will result in proceeds, after discounts, of $4.9 million for the company.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.